Patent · US Active

Substituted pyridine derivatives useful as C-FMS kinase inhibitors

US11214566B2 · kind B2 · utility

0Cited by

4References

12Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Jie Chen · Houston, US
Matthew G. Donahue · Hattiesburg, US
Heng-Keang Lim · Lawrenceville, US
Ronghui Lin · Ambler, US
Rhys Salter · Doylestown, US
Jiejun Wu · San Diego, US
Yong Gong · Warrington, US

Key dates

Filing date	Sep 2, 2020
Grant date	Jan 4, 2022
Priority date	—
Expiry date	Sep 2, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.